Segall Bryant & Hamill LLC Reduces Stock Position in Pediatrix Medical Group, Inc. (NYSE:MD)

Segall Bryant & Hamill LLC lowered its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 6.0% in the first quarter, according to its most recent 13F filing with the SEC. The fund owned 734,786 shares of the company's stock after selling 47,093 shares during the period. Segall Bryant & Hamill LLC owned approximately 0.86% of Pediatrix Medical Group worth $10,647,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. lifted its position in shares of Pediatrix Medical Group by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 10,812,611 shares of the company's stock worth $141,861,000 after buying an additional 113,976 shares in the last quarter. Boston Partners raised its holdings in shares of Pediatrix Medical Group by 25.2% in the 4th quarter. Boston Partners now owns 1,956,353 shares of the company's stock worth $25,922,000 after purchasing an additional 393,600 shares during the period. Geode Capital Management LLC raised its holdings in shares of Pediatrix Medical Group by 0.6% in the 4th quarter. Geode Capital Management LLC now owns 1,947,796 shares of the company's stock worth $25,562,000 after purchasing an additional 11,045 shares during the period. American Century Companies Inc. raised its holdings in shares of Pediatrix Medical Group by 628.2% in the 4th quarter. American Century Companies Inc. now owns 1,739,323 shares of the company's stock worth $22,820,000 after purchasing an additional 1,500,485 shares during the period. Finally, Northern Trust Corp raised its holdings in shares of Pediatrix Medical Group by 18.0% in the 4th quarter. Northern Trust Corp now owns 966,347 shares of the company's stock worth $12,678,000 after purchasing an additional 147,522 shares during the period. Institutional investors and hedge funds own 97.71% of the company's stock.

Analyst Upgrades and Downgrades

MD has been the topic of a number of research reports. UBS Group lowered their price target on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating on the stock in a report on Monday, May 12th. Truist Financial lowered their target price on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a report on Friday, April 11th. Finally, Macquarie boosted their target price on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a report on Thursday, May 8th. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, Pediatrix Medical Group has a consensus rating of "Hold" and an average target price of $16.67.

Pediatrix Medical Group Trading Down 2.1%

Pediatrix Medical Group stock traded down $0.27 during mid-day trading on Friday, hitting $12.57. The company's stock had a trading volume of 543,188 shares, compared to its average volume of 720,427. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.81 and a quick ratio of 1.81. The stock has a market cap of $1.08 billion, a price-to-earnings ratio of -12.45, a price-to-earnings-growth ratio of 0.85 and a beta of 1.25. The business has a 50 day moving average price of $13.83 and a 200-day moving average price of $13.87. Pediatrix Medical Group, Inc. has a 12 month low of $7.40 and a 12 month high of $17.67.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $0.33 earnings per share for the quarter, beating the consensus estimate of $0.25 by $0.08. Pediatrix Medical Group had a positive return on equity of 17.43% and a negative net margin of 4.17%. The business had revenue of $458.36 million for the quarter, compared to analysts' expectations of $451.44 million. During the same period in the previous year, the firm posted $0.20 EPS. The business's revenue was down 7.4% on a year-over-year basis. As a group, analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.